Gold-induced colitis: a case report and review of the literature.
A case of severe colitis requiring subtotal colectomy following administration of 35 mg Solganal b for intractable arthritis is described. Abdominal pain and watery diarrhea developed six weeks after the last dose of gold. Colonoscopy revealed mucosal edema and ulceration of the entire colon. Supportive measures failed and the patient required subtotal colectomy. Review of the literature revealed 29 cases, ranging in severity from limited ileal involvement to fulminant panenteritis. Most of the patients responded to intravenous fluids, steroids, and antibiotics, but four required surgery. The case described is notable for the delay in appearance of abdominal symptoms following the cessation of gold therapy. The mechanism of injury is unknown. Abdominal complaints in a patient who has received gold therapy, especially parenteral, merit strict attention, even if occurring several weeks after the final dose, and the diagnosis of gold colitis should be entertained.
Teodorescu
V
V
Departments of Surgery and Medicine (Gastroenterology), Mount Sinai School of Medicine (CUNY), NY.
Bauer
J
J
Lichtiger
S
S
Chapman
M
M
D000208:Acute Disease; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006051:Aurothioglucose / Q000009:adverse effects* / Q000627:therapeutic use; D003082:Colectomy; D003092:Colitis / Q000139:chemically induced* / Q000601:surgery; D005260:Female; D006801:Humans; D008875:Middle Aged
D006051:Aurothioglucose